Logo image of PTX.DE

PALANTIR TECHNOLOGIES INC-A (PTX.DE) Stock Fundamental Analysis

FRA:PTX - Deutsche Boerse Ag - US69608A1088 - Common Stock - Currency: EUR

74.18  -4.68 (-5.93%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PTX. PTX was compared to 99 industry peers in the Software industry. While PTX has a great health rating, its profitability is only average at the moment. PTX is valued quite expensive, but it does show an excellent growth. This makes PTX very considerable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PTX had positive earnings in the past year.
In the past year PTX had a positive cash flow from operations.
In multiple years PTX reported negative net income over the last 5 years.
PTX had a positive operating cash flow in 4 of the past 5 years.
PTX.DE Yearly Net Income VS EBIT VS OCF VS FCFPTX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of 7.29%, PTX is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
PTX's Return On Equity of 9.24% is fine compared to the rest of the industry. PTX outperforms 60.61% of its industry peers.
PTX's Return On Invested Capital of 4.09% is in line compared to the rest of the industry. PTX outperforms 55.56% of its industry peers.
Industry RankSector Rank
ROA 7.29%
ROE 9.24%
ROIC 4.09%
ROA(3y)0.38%
ROA(5y)-11.69%
ROE(3y)0.24%
ROE(5y)-19.79%
ROIC(3y)N/A
ROIC(5y)N/A
PTX.DE Yearly ROA, ROE, ROICPTX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

With a decent Profit Margin value of 16.13%, PTX is doing good in the industry, outperforming 73.74% of the companies in the same industry.
PTX's Operating Margin of 10.83% is fine compared to the rest of the industry. PTX outperforms 63.64% of its industry peers.
PTX has a better Gross Margin (80.25%) than 74.75% of its industry peers.
PTX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.83%
PM (TTM) 16.13%
GM 80.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.96%
GM growth 5Y3.56%
PTX.DE Yearly Profit, Operating, Gross MarginsPTX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PTX is destroying value.
The number of shares outstanding for PTX has been increased compared to 1 year ago.
Compared to 5 years ago, PTX has more shares outstanding
PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PTX.DE Yearly Shares OutstandingPTX.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
PTX.DE Yearly Total Debt VS Total AssetsPTX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 85.09 indicates that PTX is not in any danger for bankruptcy at the moment.
PTX's Altman-Z score of 85.09 is amongst the best of the industry. PTX outperforms 100.00% of its industry peers.
PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 85.09
ROIC/WACC0.29
WACC13.94%
PTX.DE Yearly LT Debt VS Equity VS FCFPTX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

PTX has a Current Ratio of 5.96. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
PTX has a better Current ratio (5.96) than 92.93% of its industry peers.
A Quick Ratio of 5.96 indicates that PTX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.96, PTX belongs to the best of the industry, outperforming 92.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.96
Quick Ratio 5.96
PTX.DE Yearly Current Assets VS Current LiabilitesPTX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

9

3. Growth

3.1 Past

PTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.00%, which is quite impressive.
The Earnings Per Share has been growing by 43.07% on average over the past years. This is a very strong growth
PTX shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.79%.
PTX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.01% yearly.
EPS 1Y (TTM)64%
EPS 3Y43.07%
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)28.79%
Revenue growth 3Y22.95%
Revenue growth 5Y31.01%
Sales Q2Q%36.03%

3.2 Future

Based on estimates for the next years, PTX will show a very strong growth in Earnings Per Share. The EPS will grow by 21.40% on average per year.
The Revenue is expected to grow by 21.04% on average over the next years. This is a very strong growth
EPS Next Y36.85%
EPS Next 2Y31.86%
EPS Next 3Y33.9%
EPS Next 5Y21.4%
Revenue Next Year34.79%
Revenue Next 2Y31.3%
Revenue Next 3Y31.94%
Revenue Next 5Y21.04%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PTX.DE Yearly Revenue VS EstimatesPTX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
PTX.DE Yearly EPS VS EstimatesPTX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 195.21 indicates a quite expensive valuation of PTX.
The rest of the industry has a similar Price/Earnings ratio as PTX.
PTX is valuated expensively when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 143.53, the valuation of PTX can be described as expensive.
64.65% of the companies in the same industry are cheaper than PTX, based on the Price/Forward Earnings ratio.
PTX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 195.21
Fwd PE 143.53
PTX.DE Price Earnings VS Forward Price EarningsPTX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PTX is valued a bit more expensive than 68.69% of the companies in the same industry.
PTX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 165.44
EV/EBITDA 527.64
PTX.DE Per share dataPTX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PTX does not grow enough to justify the current Price/Earnings ratio.
PTX's earnings are expected to grow with 33.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.3
PEG (5Y)N/A
EPS Next 2Y31.86%
EPS Next 3Y33.9%

0

5. Dividend

5.1 Amount

PTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PALANTIR TECHNOLOGIES INC-A

FRA:PTX (3/7/2025, 7:00:00 PM)

74.18

-4.68 (-5.93%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners55.02%
Inst Owner ChangeN/A
Ins Owners5.09%
Ins Owner ChangeN/A
Market Cap173.90B
Analysts56.43
Price Target86.75 (16.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.24%
Min EPS beat(2)8.41%
Max EPS beat(2)24.07%
EPS beat(4)4
Avg EPS beat(4)10.28%
Min EPS beat(4)0%
Max EPS beat(4)24.07%
EPS beat(8)7
Avg EPS beat(8)10.85%
EPS beat(12)8
Avg EPS beat(12)-7.05%
EPS beat(16)11
Avg EPS beat(16)-6.55%
Revenue beat(2)2
Avg Revenue beat(2)2.85%
Min Revenue beat(2)1.15%
Max Revenue beat(2)4.56%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)4.56%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)4
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)0.44%
PT rev (1m)75.48%
PT rev (3m)125.64%
EPS NQ rev (1m)2.6%
EPS NQ rev (3m)20.68%
EPS NY rev (1m)15.74%
EPS NY rev (3m)16.88%
Revenue NQ rev (1m)0.75%
Revenue NQ rev (3m)8.46%
Revenue NY rev (1m)1.71%
Revenue NY rev (3m)8.63%
Valuation
Industry RankSector Rank
PE 195.21
Fwd PE 143.53
P/S 65.89
P/FCF 165.44
P/OCF 163.63
P/B 37.74
P/tB 37.74
EV/EBITDA 527.64
EPS(TTM)0.38
EY0.51%
EPS(NY)0.52
Fwd EY0.7%
FCF(TTM)0.45
FCFY0.6%
OCF(TTM)0.45
OCFY0.61%
SpS1.13
BVpS1.97
TBVpS1.97
PEG (NY)5.3
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.29%
ROE 9.24%
ROCE 5.81%
ROIC 4.09%
ROICexc 190.22%
ROICexgc 190.22%
OM 10.83%
PM (TTM) 16.13%
GM 80.25%
FCFM 39.83%
ROA(3y)0.38%
ROA(5y)-11.69%
ROE(3y)0.24%
ROE(5y)-19.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.96%
GM growth 5Y3.56%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 40%
Cap/Sales 0.44%
Interest Coverage 250
Cash Conversion 337.4%
Profit Quality 246.92%
Current Ratio 5.96
Quick Ratio 5.96
Altman-Z 85.09
F-Score6
WACC13.94%
ROIC/WACC0.29
Cap/Depr(3y)87.68%
Cap/Depr(5y)87.2%
Cap/Sales(3y)1.07%
Cap/Sales(5y)1.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64%
EPS 3Y43.07%
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y36.85%
EPS Next 2Y31.86%
EPS Next 3Y33.9%
EPS Next 5Y21.4%
Revenue 1Y (TTM)28.79%
Revenue growth 3Y22.95%
Revenue growth 5Y31.01%
Sales Q2Q%36.03%
Revenue Next Year34.79%
Revenue Next 2Y31.3%
Revenue Next 3Y31.94%
Revenue Next 5Y21.04%
EBIT growth 1Y158.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.37%
EBIT Next 3Y40.26%
EBIT Next 5Y13.24%
FCF growth 1Y63.72%
FCF growth 3Y52.59%
FCF growth 5YN/A
OCF growth 1Y62.02%
OCF growth 3Y51.19%
OCF growth 5YN/A